Search Results - "Oza, Bhavna"

Reply to U. Capitanio et al by Oza, Bhavna, Eisen, Tim, Stewart, Grant D, Bex, Axel, Royston, Patrick, Meade, Angela

Get full text

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial by Eisen, Tim, Frangou, Eleni, Oza, Bhavna, Ritchie, Alastair W S, Smith, Benjamin, Kaplan, Rick, Davis, Ian D, Stockler, Martin R, Albiges, Laurence, Escudier, Bernard, Larkin, James, Bex, Axel, Joniau, Steven, Hancock, Barry, Hermann, Gregers G, Bellmunt, Joaquim, Hodgkinson, Elizabeth, Stewart, Grant D, Barber, Jim, Brown, Janet, McMenemin, Rhona, Nathan, Paul, Pickering, Lisa M, Parmar, Mahesh K B, Meade, Angela

“…SORCE is an international, randomized, double-blind, three-arm trial of sorafenib after surgical excision of primary renal cell carcinoma (RCC) found to be at…”
Get full text

External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer by Oza, Bhavna, Eisen, Tim, Frangou, Eleni, Stewart, Grant D, Bex, Axel, Ritchie, Alastair W S, Kaplan, Rick, Smith, Benjamin, Davis, Ian D, Stockler, Martin R, Albiges, Laurence, Escudier, Bernard, Larkin, James, Joniau, Steven, Hancock, Barry, Hermann, Gregers G, Bellmunt, Joaquim, Parmar, Mahesh K B, Royston, Patrick, Meade, Angela

“…The 2003 Leibovich score guides prognostication and selection to adjuvant clinical trials for patients with locally advanced renal cell carcinoma (RCC) after…”
Get full text

Surf, psychology and wellbeing: a multimodal approach to cancer survivorship by Oza, Bhavna, Reynolds, Helen, Birch-Hurst, Kayley, Mitchell, Kimberley, Maclennan, Dannie

Get full text

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse by Oza, Bhavna, Frangou, Eleni, Smith, Ben, Bryant, Hanna, Kaplan, Rick, Choodari-Oskooei, Babak, Powles, Tom, Stewart, Grant D., Albiges, Laurence, Bex, Axel, Choueiri, Toni K., Davis, Ian D., Eisen, Tim, Fielding, Alison, Harrison, David, McWhirter, Anita, Mulhere, Salena, Nathan, Paul, Rini, Brian, Ritchie, Alastair, Scovell, Sarah, Shakeshaft, Clare, Stockler, Martin R., Thorogood, Nat, Parmar, Mahesh K.B., Larkin, James, Meade, Angela

“…20–60% of patients with initially locally advanced Renal Cell Carcinoma (RCC) develop metastatic disease despite optimal surgical excision. Adjuvant strategies…”
Get full text

Making every contact count: improving the assessment of gay, bisexual and other men who have sex with men using a structured proforma by Lee, Ming J, Oza, Bhavna, Pakianathan, Mark, Hegazi, Aseel

Get more information

RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting by Meade, Angela, Oza, Bhavna, Frangou, Eleni, Smith, Ben, Bryant, Hanna, Kaplan, Rick, Choodari-Oskooei, Babak, Powles, Tom, Stewart, Grant D., Albiges, Laurence, Bex, Axel, Choueiri, Toni K., Davis, Ian D., Eisen, Tim, Fielding, Alison, Harrison, David J., McWhirter, Anita, Mulhere, Salena, Nathan, Paul, Rini, Brian, Ritchie, Alastair, Scovell, Sarah, Shakeshaft, Clare, Stockler, Martin R., Thorogood, Nat, Larkin, James, Parmar, Mahesh K.B.

“…The development of therapeutics in oncology is a highly active research area for the pharmaceutical and biotechnology industries, but also has a strong…”
Get full text

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study by Fendler, Annika, Shepherd, Scott T C, Au, Lewis, Wilkinson, Katalin A, Wu, Mary, Byrne, Fiona, Cerrone, Maddalena, Schmitt, Andreas M, Joharatnam-Hogan, Nalinie, Shum, Benjamin, Tippu, Zayd, Rzeniewicz, Karolina, Boos, Laura Amanda, Harvey, Ruth, Carlyle, Eleanor, Edmonds, Kim, Del Rosario, Lyra, Sarker, Sarah, Lingard, Karla, Mangwende, Mary, Holt, Lucy, Ahmod, Hamid, Korteweg, Justine, Foley, Tara, Bazin, Jessica, Gordon, William, Barber, Taja, Emslie-Henry, Andrea, Xie, Wenyi, Gerard, Camille L, Deng, Daqi, Wall, Emma C, Agua-Doce, Ana, Namjou, Sina, Caidan, Simon, Gavrielides, Mike, MacRae, James I, Kelly, Gavin, Peat, Kema, Kelly, Denise, Murra, Aida, Kelly, Kayleigh, O'Flaherty, Molly, Dowdie, Lauren, Ash, Natalie, Gronthoud, Firza, Shea, Robyn L, Gardner, Gail, Murray, Darren, Kinnaird, Fiona, Cui, Wanyuan, Pascual, Javier, Rodney, Simon, Mencel, Justin, Curtis, Olivia, Stephenson, Clemency, Robinson, Anna, Oza, Bhavna, Farag, Sheima, Leslie, Isla, Rogiers, Aljosja, Iyengar, Sunil, Ethell, Mark, Messiou, Christina, Cunningham, David, Chau, Ian, Starling, Naureen, Turner, Nicholas, Welsh, Liam, van As, Nicholas, Jones, Robin L, Droney, Joanne, Banerjee, Susana, Tatham, Kate C, O'Brien, Mary, Harrington, Kevin, Bhide, Shreerang, Okines, Alicia, Reid, Alison, Young, Kate, Furness, Andrew J S, Pickering, Lisa, Swanton, Charles, Gandhi, Sonia, Gamblin, Steve, Bauer, David L V, Kassiotis, George, Kumar, Sacheen, Yousaf, Nadia, Jhanji, Shaman, Nicholson, Emma, Howell, Michael, Walker, Susanna, Wilkinson, Robert J, Larkin, James, Turajlic, Samra

“…Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring (CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19…”
Get full text